Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing
NCT ID: NCT03341559
Last Updated: 2020-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
23 participants
OBSERVATIONAL
2018-03-20
2020-02-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will perform longitudinal imaging (for 12 months) in two cohorts of subjects
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Imaging For Assessment of Foot Perfusion
NCT03144050
Diabetic Foot Ulcer Imaging- Study 2
NCT03942081
Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology
NCT05968924
Remote Temperature and Visual Monitoring To Help Manage Diabetic Foot Ulcers
NCT06782386
Photoacoustic Imaging of Foot Wound
NCT07216599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With Existing Diabetic Ulcers
Current DFU
Spatial Frequency Domain Imaging (SFDI)
Observational study to measure perfusion in lower extremities for prediction of both healing and formation of diabetic foot ulcers using Reflect RS
Diabetic Ulcers in remission
DFU in remission
Spatial Frequency Domain Imaging (SFDI)
Observational study to measure perfusion in lower extremities for prediction of both healing and formation of diabetic foot ulcers using Reflect RS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spatial Frequency Domain Imaging (SFDI)
Observational study to measure perfusion in lower extremities for prediction of both healing and formation of diabetic foot ulcers using Reflect RS
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Subjects with an existing diabetic foot ulcer
2. Subjects determined "at risk" for an ulcer
Exclusion Criteria
2. Rheumatoid arthritis
3. Pregnant or lactating women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Modulated Imaging Inc.
INDUSTRY
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Armstrong
Professor of Surgery and Director, Southwestern Academic Limb Salvage Alliance (SALSA)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keck Medical Center of USC
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Murphy GA, Singh-Moon RP, Mazhar A, Cuccia DJ, Rowe VL, Armstrong DG. Quantifying dermal microcirculatory changes of neuropathic and neuroischemic diabetic foot ulcers using spatial frequency domain imaging: a shade of things to come? BMJ Open Diabetes Res Care. 2020 Nov;8(2):e001815. doi: 10.1136/bmjdrc-2020-001815.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APP-17-06886
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.